艾比森(300389.SZ):前三季度淨利預增290.03%-294.26%
格隆匯10月10日丨艾比森(300389.SZ)披露2022年前三季度業績預吿,預計2022年前三季度業績實現歸屬於上市公司股東的淨利潤1.12億元-1.15億元,同比增長290.03%-294.26%。其中,2022年第三季度歸屬於上市公司股東的淨利潤為3100.00萬元-3350.00萬元,同比增長247.64%-259.54%。
報吿期內由於疫情及經濟下行壓力的影響,中國市場營業收入同比2021年有所下滑;但隨着海外市場的全面恢復,2022年前三季度國際市場營業收入同比2021年增長接近100%;2022年公司“內外雙攻”戰略的貫徹與實施,在2022年度不確定的外部經濟環境中,為公司業績整體穩定成長提供了保障。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.